NVIDIA and Eli Lilly and Company today announced a first-of-its-kind AI co-innovation lab focused on applying AI to tackle some of the most enduring challenges in the pharmaceutical industry.

Eli Lilly (NYSE:LLY) shares climbed nearly 2% on Monday after the drugmaker announced a major artificial intelligence partnership with Nvidia (NASDAQ:NVDA).